In more than 30 years as an M&A practitioner, Charles R. Cory has advised on more than 300 successful transactions aggregating in excess of $500 billion.
Cory joined Morgan Stanley in 1982 and was appointed managing director in 1991. Early in his career he led Morgan Stanley's M&A activities in media and telecommunications (1990-92) and health care services (1992-96), as well as serving on the management committee of the department. In 1996, Cory relocated to Silicon Valley and was named worldwide head of technology M&A. In the technology space, his clients have included: Accenture, Alcatel, Amazon, Apple, Ariba, AT&T, Cisco, Compaq, Dell, eBay, EMC, Facebook, Google, Healtheon, HP, Huawei, IBM, Lucent, McAffee, Microsoft, Motorola, Netflix, Netscape, Nokia, Oracle, SAP, Seagate, Skype, Success Factors, Symantec, TPG, Time Warner AOL, VeriSign and VMWare.
Cory is a Phi Beta Kappa graduate of the University of Virginia with a B.A. in government. Prior to graduate school, he was employed by the office of the Governor of the Commonwealth of Virginia. He received his MBA and J.D. degrees from the University of Virginia Darden School of Business, where he received the William M. Shermet Award for academic excellence, and the U.Va. School of Law.
Richard W. Fisher assumed the office of president and CEO of the Federal Reserve Bank of Dallas on April 4, 2005. In this role, Fisher serves as a member of the Federal Open Market Committee, the Federal Reserve's principal monetary policymaking group.
Fisher is former vice chairman of Kissinger McLarty Associates, a strategic advisory firm chaired by former Secretary of State Henry Kissinger.
Fisher began his career in 1975 at the private bank of Brown Brothers Harriman & Co., where he specialized in fixed income and foreign exchange markets. He became assistant to the secretary of the Treasury during the Carter administration, working on issues related to the dollar crisis of 1978-79. He then returned to Brown Brothers to found their Texas operations in Dallas.
In 1987, Fisher created Fisher Capital Management and a separate funds-management firm, Fisher Ewing Partners. Fisher Ewing's sole fund, Value Partners, earned a compound rate of return of 24 percent per annum during his period as managing partner. He sold his controlling interests in both firms when he rejoined the government in 1997.
From 1997 to 2001, Fisher was deputy U.S. trade representative with the rank of ambassador. He oversaw the implementation of NAFTA and various agreements with Vietnam, Korea, Japan, Chile and Singapore. He was a senior member of the team that negotiated the bilateral accords for China's and Taiwan's accession to the World Trade Organization.
Throughout his career, Fisher has served on numerous for-profit and not-for-profit boards. He has also maintained his academic interests, teaching graduate courses and serving on several university boards. Fisher serves on Harvard University's Board of Overseers, one of the university's two governing boards. He was a Weatherhead Fellow at Harvard in 2001, is an honorary fellow of Hertford College at Oxford University, and is a fellow of the American Academy of Arts & Sciences.
A first-generation American, Fisher is equally fluent in Spanish and English, having spent his formative years in Mexico. He attended the U.S. Naval Academy (1967-69), graduated with honors from Harvard University in economics (1971), read Latin American politics at Oxford (1972-73) and received an M.B.A. from Stanford University (1975).
In October of 2006, Fisher received the Service to Democracy Award and Dwight D. Eisenhower Medal for Public Service from the American Assembly. In April 2009, he was inducted into the Dallas Business Hall of Fame.
W. Barnes Hauptfuhrer is chief executive officer of Chapter IV Investors, LLC, an investment firm he founded in February 2006. He serves as the Portfolio Manager of Chapter IV Investors Special Situations Fund, L.P. (the "Fund"), a long-biased, concentrated hedge fund that opportunistically utilizes long/short and event-driven strategies. The Fund is a value-oriented investor that focuses on making long-term investments based on deep fundamental research and active interaction with management.
Hauptfuhrer previously served as Co-Head of the Corporate & Investment Banking Division of Wachovia Corporation, formerly First Union Corporation ("First Union"), a financial services corporation, from January 1999 to May 2004.
Prior to this, Hauptfuhrer founded and served as managing partner of First Union Capital Partners, a private equity investment group within First Union from April 1988 to December 1998, and was an investment banker, specializing in mergers and acquisitions, with Kidder Peabody in New York from 1981-1988.
Hauptfuhrer graduated from Princeton University with an AB degree in 1976 and the University of Virginia with a JD/MBA degree in 1981.
Robert J. Hariri, M.D., Ph.D. is Chairman, Founder & Chief Scientific Officer Celgene Cellular Therapeutics. Dr. Hariri is considered a visionary serial entrepreneur in biomedicine. The Chairman, Founder and Chief Scientific Officer of one of the world's largest human cellular therapeutics companies, Dr. Hariri has pioneered the use of stem cells and biomaterials to treat a range of life threatening diseases. His activities and experience includes academic neurosurgeon at Cornell, executive, military and defense scientist and surgeon and aviator and aerospace innovator. Dr. Hariri has 100 issued and pending patents, has authored over 100 published chapters, articles and abstracts and is most recognized for his discovery of pluripotent stem cells from the placenta and as a member of the team which discovered TNF (tumor necrosis factor). Dr. Hariri was recipient of the Thomas Alva Edison Award in 2007 and 2011, and has received numerous other honors for his many contributions to biomedicine and aviation. Dr. Hariri is also the Founder and Chairman of Myos Corporation, a bionutrition and biotherapeutics company and the Vice-chairman and Co-founder of Human Longevity, Inc., a genomics and cell-therapy company.
Dr. Hariri serves on numerous Boards of Directors including Myos Corporation and Provista Diagnostics and is a member of the Board of Visitors of the Columbia University School of Engineering & Applied Sciences and the Science & Technology Council of the College of Physicians and Surgeons; as well as a member of the Scientific Advisory Board for the Archon X PRIZE for Genomics, which is awarded by the X Prize Foundation. Dr. Hariri is also a Trustee of the J. Craig Venter Institute and the Liberty Science Center and has been appointed Commissioner of Cancer Research by New Jersey Governor, Chris Christie. Dr. Hariri received his undergraduate training at Columbia College and Columbia University School of Engineering and Applied Sciences and was awarded his M.D. and Ph.D. degrees from Cornell University Medical College. Dr. Hariri received his surgical training at The New York Hospital-Cornell Medical Center where he also directed the Aitken Neurosurgery Laboratory and the Center for Trauma Research.
Ned Hooper is currently a Partner with Centerview Capital leading the firm's technology growth and private equity investment practice. He serves on the Board of Directors for InfiniteZ, a start-up driving innovation in immersive, holographic platforms; the Board of Advisors for Think Big Analytics, a leader in big data consulting; and as a Trustee for the Darden Graduate School of Business at the University of Virginia.
Previously, Ned was Senior Vice President and Chief Strategy Officer at Cisco. He drove the development of Cisco's business vision and strategy to identify market transitions across customer segments and developed integrated strategies that leveraged all Cisco assets. He was a member of the Operating Committee and partnered closely with the Chief Operating Officer to tie strategy to operational excellence and to institutionalize a strategy discipline throughout the company. As part of this role, he was responsible for business development activities including acquisitions, equity investments, and the incubation of innovative technologies. Ned led over seventy-five acquisitions that played a key role in driving Cisco's growth strategy, resulting in revenue growth from $18B to over $46B over 10 years and earnings growth over 14%. Under Hooper's leadership, Cisco broadly expanded its global private investment strategy with a portfolio of investments spanning early stage technology innovation to mature go-to-market partners, resulting in strong strategic and financial returns.
Prior to joining Cisco, He was responsible for building and implementing a global distribution strategy for Lightspeed International, a start-up acquired by Cisco. He began his career in technology with MCI in Product Management.
Hooper holds a bachelor's degree from the University of Colorado and a master's degree in business administration from the Darden School of Business at the University of Virginia.
Robert J. Hugin (Darden '85) is chairman and chief executive officer of Celgene Corporation, a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for unmet medical needs in cancer and immune-inflammatory disease. Mr. Hugin currently serves as the chairman of The Pharmaceutical Research and Manufacturers of America. Previously, he was a managing director with J.P. Morgan & Co. Inc. He received an A.B. degree from Princeton University in 1976 and an MBA from the University of Virginia in 1985 having served as a United States Marine Corps infantry officer during the intervening period. Mr. Hugin serves as a member of the Board of Trustees of Princeton University and also serves as director of The Medicines Company, Atlantic Health System, Inc. and of Family Promise, a national non-profit network assisting homeless families.
Samuel D. Isaly is the Managing Partner of OrbiMed Advisors. Mr. Isaly is one of the world's most recognized healthcare fund managers and has been active in global healthcare investing and analysis since 1968 when he joined Chase Manhattan Bank in New York. During his career, Mr. Isaly has been a pharmaceutical analyst with Chase Manhattan Bank, Merrill Lynch, Legg Mason, and S.G. Warburg. Mr. Isaly launched OrbiMed's asset management business in 1989. Mr. Isaly has a B.A. in Economics from Princeton University and a M. Sc. (Econ.) from The London School of Economics.
Nancy R. Lazar leads the Economic Research team of Cornerstone Macro. Nancy's work as an economist is renowned for its forward-looking and detail-oriented insights. Before founding Cornerstone, she was the Vice Chairman and Co-Founder of ISI Group for over 20 years. Nancy has been an Institutional Investor-ranked economist for the past 12 years, and has been ranked #2 for the past 4 years. Prior to founding ISI in 1991, Nancy was a Senior Vice President at CJ Lawrence. Nancy graduated from Kalamazoo College in 1979. She is a member of The Economic Club of New York, New York Forecasters, Money Marketeers, NYABE, NABE, and Women in Finance & Housing.
John Siegel is a partner at Columbia Capital. John joined Columbia Capital in 2000 and focuses on Internet Infrastructure and Enterprise IT Services investments. John is currently a member of the Board of Directors of GTS SK, euNetworks, CloudSherpas, Summit IG, TerraPact, Cologix and Virtustream. John previously served on the boards of Zayo, ICG Communications (acquired by Level 3), New Global Telecom (acquired by Comcast), Presidio (acquired by American Securities), mindSHIFT (acquired by Best Buy), and FDN Communications (acquired by NuVox) and represented Columbia Capital's interests in Mpower Communications (acquired by TelePacific). Before joining Columbia Capital, John worked in Morgan Stanley's Private Equity Group, where he specialized in investments in the telecommunications/data services arena. He also held positions with Fidelity Ventures, the private equity division of Fidelity Investments, and the Investment Banking Division of Alex. Brown & Sons, Incorporated. John received his B.A. from Princeton University and his M.B.A. from Harvard Business School.
Michael F. Sola is a vice president of T. Rowe Price Group Inc. and T. Rowe Price Associates Inc., and a sector portfolio manager in the U.S. Equity Division. Sola is a vice president and Investment Advisory Committee member of the Science & Technology, Growth Stock, New Horizons, and Small-Cap Stock Funds. Prior to joining the firm in 1995, he was a systems analyst at SRA Corporation. Sola earned a B.S. in physics and economics from the College of William & Mary and an MBA in finance and accounting from the University of Chicago Booth School of Business. He also earned the Chartered Financial Analyst designation.
Kathy Warden is corporate vice president and president of Northrop Grumman's Information Systems (IS) sector, an approximately $6.5 billion leading global provider of advanced solutions for defense, intelligence, civil agency and commercial customers. She is also on the company's Corporate Policy Council.
Ms. Warden oversees large-scale, mission-critical systems and complex hardware and software products across the globe related to command, control and communications; cyber and identity management; homeland security; health, public safety and enterprise infrastructure; and intelligence, surveillance and reconnaissance and ground systems. Previously, Ms. Warden was vice president and general manager of the IS sector's Cyber Intelligence division. Earlier, she held leadership roles at General Dynamics and Veridian Corporation, was a principal in a venture Internet firm, and spent nearly a decade with General Electric Company.
Ms. Warden earned a bachelor's degree from James Madison University and a master's degree in business administration from George Washington University.